|
|
News Breaks | | | | March 19, 2013 | | 06:32 EDT |  | ABC, WAG | AmerisourceBergen enters into relationship with Walgreen and Alliance Boots
AmerisourceBergen (ABC) announced that it is entering into a strategic, long-term relationship with Walgreen (WAG) and Alliance Boots, which will streamline the distribution of pharmaceuticals to Walgreens' stores and leverage global supply chain efficiencies while improving patient access to affordable pharmaceuticals to increase the efficiency of the healthcare system. AmerisourceBergen's new expanded relationship with Walgreens and Alliance Boots includes: a ten-year comprehensive primary pharmaceutical distribution contract with Walgreens; access to generic drugs and related pharmaceutical products through the Walgreens Boots Alliance Development joint venture; and opportunities to accelerate the Company's efforts to grow its specialty and manufacturer services businesses domestically and internationally. In furtherance of this new partnership, Walgreens and Alliance Boots together have been granted rights to purchase an equity position in AmerisourceBergen, which is described in greater detail below. The new agreements are expected to be meaningfully accretive to AmerisourceBergen's earnings and strengthen its confidence in delivering solid and sustainable long-term EPS growth. | |
|
News For ABC;WAG From The Last 14 Days Check below for free stories on ABC;WAG the last two weeks. |
|
|
| May 20, 2013 | | 15:52 EDT |  | WAG | Walgreen downgraded to Market Perform from Outperform at Barrington
 Subscribe for More Information | | | May 17, 2013 | | 12:33 EDT | | ABC, WAG | AmerisourceBergen receives approval of Walgreens, Alliance Boots investment
AmerisourceBergen (ABC) announced that the parties have received regulatory approval of the previously disclosed agreement for Walgreen (WAG) and Alliance Boots GmbH to purchase an equity stake in the company. AmerisourceBergen continues to expect the new agreements to contribute an incremental $25B in revenues and approximately 20c in earnings per share in FY14, excluding the amortization of certain expenses related to the transaction and the warrants issued, certain non-recurring costs and a potential LIFO charge, and net of certain start up expenses. In addition, the company reiterated its expectations for financial performance for fiscal year 2013, which includes expected revenue growth in the 11%-13% range, and diluted earnings per share from continuing operations in the lower half of the range of $3.04 to $3.14, excluding certain expenses related to the relationship with Walgreens and Alliance Boots and the warrants issued, and the expected LIFO charge from onboarding of additional branded inventory. | | | May 14, 2013 | | 07:18 EDT |  | ABC | BofA/Merrill to host a conference
2013 Health Care Conference is being held in Las Vegas on May 14-16. | | | May 13, 2013 | | 08:32 EDT | | WAG | Walgreens extends CVS Caremark network provider agreement
Subscribe for More Information | | | 08:05 EDT | | ABC | Frazier Healthcare acquires AnderesonBrecon from AmerisourceBergen
Subscribe for More Information | | | 07:32 EDT | | ABC | AmerisourceBergen says divestiture of AndersonBrecon has no impact on guidance
Subscribe for More Information | |
|
|
|
|
|
|
